
Sign up to save your podcasts
Or


Editor’s Choice: A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer
By Gynecologic Oncology5
1818 ratings
Editor’s Choice: A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer

25,828 Listeners

87,249 Listeners

112,401 Listeners

56,702 Listeners

34 Listeners

1,809 Listeners

10,867 Listeners